ABSTRACT
In this final article in a series of three, components of pessary fitting, provision, and follow up are reviewed from a business perspective related to supplies, patient flow, billing, and coding.
Subject(s)
Commerce/organization & administration , Nurse Practitioners/organization & administration , Office Management/organization & administration , Pessaries/supply & distribution , Prosthesis Fitting/nursing , Specialties, Nursing/organization & administration , Aged , Commerce/economics , Education, Nursing, Continuing , Female , Humans , Nurse Practitioners/economics , Office Management/economics , Pessaries/economics , Prosthesis Fitting/economics , Specialties, Nursing/economicsSubject(s)
Commerce/organization & administration , Nurse Practitioners/organization & administration , Office Management/organization & administration , Pelvic Organ Prolapse , Pessaries/adverse effects , Pessaries/supply & distribution , Prosthesis Fitting/nursing , Specialties, Nursing/methods , Specialties, Nursing/organization & administration , Vaginal Diseases , Female , HumansSubject(s)
Commerce/organization & administration , Nurse Practitioners/organization & administration , Office Management/organization & administration , Pelvic Organ Prolapse , Pessaries/adverse effects , Pessaries/supply & distribution , Prosthesis Fitting/nursing , Specialties, Nursing/methods , Specialties, Nursing/organization & administration , Vaginal Diseases , Female , HumansABSTRACT
Pelvic organ prolapse is a common female complaint, with 50% of women experiencing some degree of pelvic relaxation, although not all have any symptoms. Prolapse is found most commonly in the anterior vaginal walls. Posterior vaginal wall and apical prolapse are the other, less common, categories. There are a large number of potential risk factors, but increased age, parity and body mass index are most consistently reported. A variety of symptoms may be experienced, including a feeling of something coming down, pelvic heaviness, urinary, bowel and sexual dysfunction. Two main treatment options exist, conservative management (pessary or pelvic floor rehabilitation) or surgical repair, however the evidence-base for treatment is weak. The specialist nurse is well-placed to contribute to the initial assessment, management and ongoing support of women with prolapse.
Subject(s)
Nurse's Role , Uterine Prolapse/diagnosis , Uterine Prolapse/therapy , Disease Progression , Equipment Design , Exercise Therapy , Female , Humans , Life Style , Nurse Clinicians , Patient Care Team , Patient Education as Topic , Pelvic Floor , Pessaries/supply & distribution , Prevalence , Risk Factors , United Kingdom/epidemiology , Uterine Prolapse/classification , Uterine Prolapse/epidemiology , Uterine Prolapse/etiologyABSTRACT
Jeanette Haslam explains the theory that underpins the use of vaginal cones in stress urinary incontinence and how this translates into practice.
Subject(s)
Exercise Therapy/methods , Pelvic Floor , Pessaries , Urinary Incontinence, Stress/rehabilitation , Activities of Daily Living , Evidence-Based Medicine , Exercise Therapy/instrumentation , Female , Humans , Patient Education as Topic , Pessaries/supply & distribution , Time Factors , Treatment Outcome , Urinary Incontinence, Stress/etiologySubject(s)
Urinary Incontinence/prevention & control , Urinary Retention/prevention & control , Women's Health , Activities of Daily Living , Biofeedback, Psychology/instrumentation , Catheters, Indwelling/supply & distribution , Diapers, Adult/supply & distribution , Equipment Design , Exercise Therapy/instrumentation , Female , Humans , Nurse Practitioners , Nurse's Role , Patient Selection , Pelvic Floor , Pessaries/supply & distribution , Quality of Life , Urinary Catheterization/instrumentationABSTRACT
It is estimated that 10 million women in the UK suffer with urinary incontinence (Hunskarr et al, 2004). Many women consider bladder weakness to be an inevitable consequence of childbirth or the menopause. Haslam (2004) reported on a telephone survey that examined whether women were aware of stress urinary incontinence, their attitude to it and the impact it had on their daily lives. In the UK, 505 women were interviewed, 206 of whom responded positively to a question about symptoms of stress urinary incontinence, giving a prevalence rate of 41 per cent. There is also evidence that most patients with urinary incontinence do not present to their doctors
Subject(s)
Exercise Therapy/instrumentation , Incontinence Pads , Urinary Catheterization/instrumentation , Urinary Incontinence/rehabilitation , Women's Health , Adaptation, Psychological , Adult , Aged , Aged, 80 and over , Attitude to Health , Drainage/instrumentation , Female , Health Knowledge, Attitudes, Practice , Humans , Incontinence Pads/supply & distribution , Middle Aged , Pelvic Floor , Pessaries/supply & distribution , Prevalence , Quality of Life , Surveys and Questionnaires , United Kingdom/epidemiology , Urinary Incontinence/epidemiology , Urinary Incontinence/psychology , Women/education , Women/psychologySubject(s)
Pessaries , Urinary Incontinence/prevention & control , Uterine Prolapse/prevention & control , Equipment Design , Female , Humans , Nurse Practitioners , Nurse's Role , Patient Acceptance of Health Care/psychology , Patient Selection , Pessaries/adverse effects , Pessaries/classification , Pessaries/statistics & numerical data , Pessaries/supply & distribution , Prosthesis Fitting , Treatment Outcome , Women/education , Women/psychology , Women's HealthABSTRACT
A number of vaginal and urethral devices have recently been introduced for the treatment of female urinary stress incontinence. Nine recent studies of these were scrutinized. The median corrected subjective cured/improved rate was 63% for the vaginal and 43% for the urethral devices. The latter group have a high percentage of side-effects with related drop-outs. Urinary tract infection and migration of the device into the bladder are particularly worrying. The vaginal devices currently available compete favourably with other non-surgical forms of therapy for stress incontinence in terms of efficacy and safety.
